We are pleased that our RealBrain® technology is highlighted in the recently launched AusBiotech and RM Catalyst comprehensive report "The Regenerative Medicine Value Chain". Check it out at https://t.co/KXHM34zAae
We are excited to announce our partnership with @TessaraTx. CCRM Au will assist w/ the collaboration between their RealBrain® drug screening and #RegenerativeMedicine platforms and our network of researchers, institutions and partners.
Tessara pleased to have recently joined @NeuroSciVic as an Industry Affiliate. We are excited to be a partner of one of the leading #neuroscience organisations and networks in #victoria and #australia.
This week marks 15 years since the founding of Bio-Link! Thanks to our staff, interns and alumni, clients, colleagues and friends for helping build our business, contributing to biomedical innovation and building a strong biopharma industry #commercialisation; #drugdevelopment;
With just under 100 trials planned for 2020, Australia is ranked the country with the third most clinical trials slated for this year in @globaldataplc's annual outlook report, “The State of the Biopharmaceutical Industry – 2020”.
#Biotechnology
What a week! Bio-Link was delighted to represent our client,
@ActinogenMed, at #JPM2020. We travelled over 31 km (generally on foot) around San Francisco, meeting with leading pharma executives, sharing the latest exciting data and future strategy for the development of #Xanamem
Bridging the gap between science & business.
Don’t miss out on the Symposium co-hosted by Bio-Link partner @CCRM_au and the NSW Stem Cell Network. Come and learn more about accelerating commercialisation of #regenerativemedicine.
Register: https://t.co/42ftTWx8OC
The Sacred Word: De-risking biotech messaging panel event at #AusBio19 was a success!
If you’d like to learn more about this subject, read the @Ausbiotech article (https://t.co/CclwBMozUe) or contact Bio-Link (https://t.co/BFZif2gYPe).
Are you interested in global business development for your company? Join us at @AusBiotech’s annual conference, #AusBio19, and meet Bio-Link's Lilly Bojarski, Senior Business Development Associate.
Learn more: https://t.co/t4Wr8dB17g
Bio-Link is pleased to see the progression of a client's technology, as the basis of a $20M Series A funding of Kira Biotech (https://t.co/SP62PFXIWn). The technology was incubated over the last few years through an earlier deal (https://t.co/fmvmZRxmgb) facilitated by Bio-Link.
We are delighted to welcome Kate Samardzic to the Bio-Link team as a Business Development Associate.
Learn more about Kate and the rest of the Bio-Link team: https://t.co/LHGadtrOj5.
#biotechnology
Take a sneak peek at @AusBiotech ’s 2019 national conference with @BioLinkAus Executive Director @CToouli ’s article “The Sacred Word: De-risking biotech messaging”.
Read it in the new edition of Australasian Biotechnology (pg 36): https://t.co/CclwBMozUe
#Biotechnology
The @US_FDA has launched an initiative in collaboration with @TGAgovau and @GovCanHealth to allow the regulatory review of #cancer products to occur in parallel across different countries - Project Orbis.
#Biotechnology
Find out more: https://t.co/RgvN8AhdG1
Congratulations to @ActinogenMed for their breakthrough results from the XanaHES (Xanamem in Healthy Elderly Subjects) trial! Results show a significant improvement in cognition in trial participants dosed with Xanamem.
ASX Announcement: https://t.co/wizw4ViqwU
#Alzheimers